IP Library Granted Patent US 10,287,327
Granted Patent B2
US 10,287,327 · App. 14/778,395 · Granted May 14, 2019

Protein A mutants having high alkali resistance and methods of use thereof

Inventors: Hong Qian (Nanjing, CN); Tao Bai (Nanjing, CN); Rong Hua (Nanjing, CN)
Assignee: Nanjingjinsirui Science & Technology Biology Corp.
C07K14/31C07K1/22C07K16/00G01N33/6854C07K2319/21C07K2319/705
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,287,327
App. No.
14/778,395
Granted
May 14, 2019
Kind
B2
Abstract

A series of protein A mutants having high alkali resistance, and methods of using the protein A mutants are provided. The protein A mutants have a high binding affinity for regions of immunoglobulin proteins other than the complementarity determining regions. The protein A mutants can be coupled to a solid support for immunoglobulin isolation, or conjugated to a label for immunoglobulin detection. This series of protein A mutants has high chemical stability under alkaline conditions of pH 13-14, and can also be used as chromatography ligands for purification procedures that use alkaline solutions under harsh conditions, such as Clean-In-Place (CIP). Also provided are methods of immunoglobulin separation and purification, and alkali regeneration of affinity chromatography medium that uses protein A as a ligand.

Claims (2)

1. A recombinantly expressed mutant protein A molecule for isolating, purifying, or detecting an immunoglobulin, wherein the mutant protein A molecule comprises the amino acid sequence of SEQ ID NO: 1, the amino acid sequence of SEQ ID NO: 2, the amino acid sequence of residues 7 to 54 of SEQ ID NO: 1, or the amino acid sequence of residues 7 to 54 of SEQ ID NO: 2.

2. The recombinantly expressed mutant protein A molecule of claim 1 , wherein the mutant protein A molecule is stable under alkaline conditions of pH 13-14.

Assignments (5)
CHANGE OF NAME Recorded Apr 9, 2021
From: NANJINGJINSIRUI SCIENCE & TECHNOLOGY BIOLOGY CORP.
To: NANJING GENSCRIPT BIOTECH CO., LTD.
Reel/Frame 055886/0741 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE DATA PREVIOUSLY RECORDED ON REEL 036723 FRAME 0772. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNOR'S INTEREST. Recorded Feb 20, 2019
From: QIAN, HONG; BAI, TAO; HUA, RONG
To: NANJINGJINSIRUI SCIENCE & TECHNOLOGY BIOLOGY CORP.
Reel/Frame 048379/0236 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE DATA PREVIOUSLY RECORDED ON REEL 036854 FRAME 0411. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNOR'S INTEREST. Recorded Feb 20, 2019
From: QIAN, HONG; BAI, TAO; HUA, RONG
To: NANJINGJINSIRUI SCIENCE & TECHNOLOGY BIOLOGY CORP.
Reel/Frame 048379/0398 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2015
From: QIAN, HONG; BAI, TAO; HUA, RONG
To: NANJING GENSCRIPT CO., LTD
Reel/Frame 036854/0411 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2015
From: QIAN, HONG; BAI, TAO; HUA, RONG
To: NANJING GENSCRIPT CO., LTD
Reel/Frame 036723/0772 →
Priority Claims (1)
CN 2013 1 0087284 · Mar 18, 2013 · national
Continuity (1)
Related Publication 20160237124A1 · Aug 18, 2016